Cargando…

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B

Aim: Liver fibrosis monitoring is essential in patients with chronic hepatitis B (CHB). However, less robust, noninvasive diagnostic methods for staging liver fibrosis, other than liver biopsy, are available. Our previous study demonstrated a panel of cellular proteins recognized by autoantibodies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Saiping, Li, Jing, He, Xiaomin, Zhou, Jialing, Chen, Zhibin, Li, Xiaojin, Zhang, Bei, Ma, Hong, You, Hong, Huang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764302/ https://www.ncbi.nlm.nih.gov/pubmed/35059422 http://dx.doi.org/10.3389/fmed.2021.807087

Ejemplares similares

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma
por: Li, Xiaojin, et al.
Publicado: (2021)

A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients
por: Xu, Xueying, et al.
Publicado: (2021)

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
por: Kirgou, Paraskevi, et al.
Publicado: (2022)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Are sputum autoantibodies more clinically relevant in idiopathic pulmonary fibrosis than serum autoantibodies?
por: Deng, Kuimiao, et al.
Publicado: (2022)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus Infection
por: Fujita, Koji, et al.
Publicado: (2018)

Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive
por: Wang, Hong, et al.
Publicado: (2017)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2021)

A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis
por: Mercedes, Rebecca, et al.
Publicado: (2020)

Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review
por: Kamiya, Hiroyuki, et al.
Publicado: (2018)

Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma
por: Tong, Yong-Qing, et al.
Publicado: (2011)

Macrophage polarization is involved in liver fibrosis induced by β (1)-adrenoceptor autoantibody : β (1)-Adrenoceptor autoantibody and liver fibrosis
por: Wu, Ye, et al.
Publicado: (2022)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
por: Cho, Hyo Jung, et al.
Publicado: (2014)

Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
por: Wu, Cichun, et al.
Publicado: (2021)

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”
por: Fujita, Koji, et al.
Publicado: (2021)

Serum Autoantibody Biomarkers for Management of Rheumatoid Arthritis Disease
por: Sánchez-Tirado, Esther, et al.
Publicado: (2023)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease
por: Raghu, Chantel, et al.
Publicado: (2018)

Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients
por: Bhat, Mamatha, et al.
Publicado: (2017)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B
por: Huang, Haijun, et al.
Publicado: (2016)

Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D
por: Abbas, Minaam, et al.
Publicado: (2017)

A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

Autoantibody-Specific Signalling in Pemphigus
por: Schmitt, Thomas, et al.
Publicado: (2021)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

Therapeutic effects of serum extracellular vesicles in liver fibrosis
por: Chen, Li, et al.
Publicado: (2018)

Non-organ-specific autoantibodies with unspecific patterns are a frequent para-infectious feature of chronic hepatitis D
por: Hermanussen, Lennart, et al.
Publicado: (2023)

Editorial: Cardiovascular Fibrosis and Related Diseases: Basic and Clinical Research Advances
por: Bei, Yihua, et al.
Publicado: (2022)

Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital
por: Carter, John B., et al.
Publicado: (2018)

Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome
por: You, Hongqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7o40j0ne0m97u1qskvvb6tuhus